Other

Liabilities, Noncurrent, Fair Value Disclosure

Pfizer Liabilities, Noncurrent, Fair Value Disclosure increased by 11.1% to $3.03B in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2025
Last reportedQ1 2026
Metric ID: other_liabilities_noncurrent_fair_value_disclosure

Historical Data

2 periods
 Q4 '25Q1 '26
Value$2.73B$3.03B
QoQ Change—+11.1%
Range$2.73B – $3.03B

Frequently Asked Questions

What is Pfizer's liabilities, noncurrent, fair value disclosure?
Pfizer (PFE) reported liabilities, noncurrent, fair value disclosure of $3.03B in Q1 2026.